For instance, in experimental autoimmune encephalomyelitis, two potent AhR agonists, TCCD and FICZ, have opposing effects in which the former decreases Th17 differentiation while the latter increases Th17 cells [45]. This evidence concerns the gene AHR and experimental autoimmune encephalomyelitis.